Stock Yards Bank & Trust Co Has Decreased By $1.66 Million Its Schlumberger LTD (SLB) Stake; Shorts at Tetraphase Pharmaceuticals (TTPH) Raised By 17.12%

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Logo

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) had an increase of 17.12% in short interest. TTPH’s SI was 3.62M shares in April as released by FINRA. Its up 17.12% from 3.09 million shares previously. With 1.52M avg volume, 2 days are for Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)’s short sellers to cover TTPH’s short positions. The SI to Tetraphase Pharmaceuticals Inc’s float is 7.46%. The stock increased 2.87% or $0.09 during the last trading session, reaching $3.23. About 787,636 shares traded. Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) has declined 65.91% since April 23, 2017 and is downtrending. It has underperformed by 77.46% the S&P500.

Stock Yards Bank & Trust Co decreased Schlumberger Ltd (SLB) stake by 13.89% reported in 2017Q4 SEC filing. Stock Yards Bank & Trust Co sold 24,762 shares as Schlumberger Ltd (SLB)’s stock declined 4.39%. The Stock Yards Bank & Trust Co holds 153,520 shares with $10.35 million value, down from 178,282 last quarter. Schlumberger Ltd now has $95.95 billion valuation. The stock decreased 1.49% or $1.05 during the last trading session, reaching $69.23. About 9.97 million shares traded or 21.95% up from the average. Schlumberger Limited (NYSE:SLB) has declined 16.28% since April 23, 2017 and is downtrending. It has underperformed by 27.83% the S&P500.

Among 16 analysts covering Tetraphase Pharmaceuticals (NASDAQ:TTPH), 8 have Buy rating, 0 Sell and 8 Hold. Therefore 50% are positive. Tetraphase Pharmaceuticals has $57 highest and $3 lowest target. $17.08’s average target is 428.79% above currents $3.23 stock price. Tetraphase Pharmaceuticals had 35 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Robert W. Baird to “Neutral” on Wednesday, September 9. BMO Capital Markets maintained Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) rating on Wednesday, June 21. BMO Capital Markets has “Buy” rating and $11.7600 target. The rating was downgraded by Stifel Nicolaus to “Hold” on Wednesday, September 9. The rating was downgraded by SunTrust on Wednesday, September 9 to “Neutral”. FBR Capital maintained it with “Buy” rating and $6.0 target in Tuesday, February 27 report. The firm has “Outperform” rating given on Wednesday, July 26 by BMO Capital Markets. Needham maintained the shares of TTPH in report on Thursday, August 3 with “Hold” rating. The stock of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) has “Buy” rating given on Thursday, November 19 by SunTrust. The stock has “Buy” rating by Brean Capital on Thursday, August 6. On Wednesday, July 26 the stock rating was upgraded by Stifel Nicolaus to “Buy”.

Tetraphase Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. The company has market cap of $166.77 million. The Company’s lead product candidate is eravacycline, an intravenous and oral antibiotic for use as a first-line empiric monotherapy to treat resistant and multidrug-resistant infections, including multidrug-resistant Gram-negative infections. It currently has negative earnings. The firm has completed a Phase III clinical trial of eravacycline with intravenous administration for the treatment of complicated intra-abdominal infections; and initiated a Phase III clinical trial of eravacycline for the treatment of complicated urinary tract infections with intravenous-to- oral transition therapy.

Investors sentiment decreased to 1.19 in 2017 Q4. Its down 1.02, from 2.21 in 2017Q3. It dropped, as 11 investors sold Tetraphase Pharmaceuticals, Inc. shares while 25 reduced holdings. 16 funds opened positions while 27 raised stakes. 29.51 million shares or 0.43% more from 29.38 million shares in 2017Q3 were reported. Tekla Cap Limited Liability Co holds 0.21% or 859,322 shares in its portfolio. Susquehanna International Grp Incorporated Ltd Liability Partnership holds 0% or 18,626 shares in its portfolio. Legal & General Grp Public Ltd Com stated it has 13,077 shares or 0% of all its holdings. Ellington Management Group Ltd accumulated 27,000 shares. Ameriprise invested in 22,500 shares. Mufg Americas Hldg Corp reported 466 shares or 0% of all its holdings. Fmr Ltd Company owns 989,234 shares or 0% of their US portfolio. Dimensional Fund L P invested 0% in Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH). 13,870 are owned by Metropolitan Life Ins. Vanguard Gru Inc accumulated 2.09M shares. Balyasny Asset Mngmt Limited Com owns 438,829 shares. Schwab Charles Investment Mgmt Inc reported 243,869 shares stake. Ameritas Investment Prtn Inc reported 0% stake. Morgan Stanley stated it has 0% in Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH). Teton Advisors holds 0.02% or 30,000 shares in its portfolio.

Since January 9, 2018, it had 0 buys, and 2 insider sales for $98,932 activity. Another trade for 7,167 shares valued at $44,507 was made by Dumas Jacques on Tuesday, January 9.

Among 39 analysts covering Schlumberger Limited. (NYSE:SLB), 32 have Buy rating, 1 Sell and 6 Hold. Therefore 82% are positive. Schlumberger Limited. has $120 highest and $70 lowest target. $84.16’s average target is 21.57% above currents $69.23 stock price. Schlumberger Limited. had 144 analyst reports since July 22, 2015 according to SRatingsIntel. DA Davidson initiated Schlumberger Limited (NYSE:SLB) on Friday, February 19 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Friday, September 29. The stock of Schlumberger Limited (NYSE:SLB) has “Hold” rating given on Monday, July 11 by Jefferies. Societe Generale downgraded Schlumberger Limited (NYSE:SLB) rating on Thursday, April 28. Societe Generale has “Hold” rating and $86 target. The rating was maintained by Wells Fargo with “Buy” on Friday, October 20. The stock of Schlumberger Limited (NYSE:SLB) earned “Hold” rating by Suntrust Robinson on Wednesday, January 18. The firm earned “Buy” rating on Friday, March 24 by Tudor Pickering. UBS maintained it with “Buy” rating and $90.0 target in Wednesday, September 30 report. On Wednesday, April 4 the stock rating was maintained by Jefferies with “Buy”. RBC Capital Markets maintained Schlumberger Limited (NYSE:SLB) on Friday, September 1 with “Buy” rating.

Since October 24, 2017, it had 3 insider purchases, and 2 insider sales for $6.71 million activity. $1.96M worth of stock was sold by Guild Howard on Monday, January 22. Another trade for 75,000 shares valued at $5.91 million was sold by AYAT SIMON. $323,950 worth of Schlumberger Limited (NYSE:SLB) shares were bought by Schorn Patrick. $219,205 worth of stock was sold by SANDVOLD TORE I on Tuesday, October 24. KIBSGAARD PAAL also bought $646,800 worth of Schlumberger Limited (NYSE:SLB) shares. $192,900 worth of Schlumberger Limited (NYSE:SLB) was bought by Al Mogharbel Khaled on Wednesday, March 28.

Schlumberger Limited (NYSE:SLB) Institutional Positions Chart